Remote Patient Monitoring (RPM) technologies are changing the way healthcare is delivered, but their particular effects on pharmacy practice, especially in medication management, as well as in pharmacovigilance and clinical decision-making are not sufficiently synthesized. To map and synthesize technological solutions in RPM and assess their potential to assist pharmacist-led medication optimization, safety surveillance, and data-driven virtual care. This scoping review was carried out on the basis of the framework offered by Arksey and O’Malley, and it was refined in accordance with the recommendations provided by Joanna Briggs Institute, and reported in line with PRISMA-ScR standards. Literature in English related to the field published since 2010 was searched in five databases (PubMed, Scopus, Web of Science, IEEE Xplore, and Google scholar). Out of 1432 records found, 282 were duplicates and 1150 were screened. After conducting full-text evaluation of 150 articles, 48 articles had met inclusion criteria. various reported clinical settings involved in RPM are: multiple setting (n = 28), Home setting (n = 4), remote monitoring programs (n = 1), clinical setting (n = 2), healthcare setting (n = 6), pharmacy setting (n = 4), comprehensive remote monitoring (n = 1), telepharmacy (n = 1), community pharmacy (n = 1). It was found that there are five technological areas, namely, wearable biosensors, Internet of Things connectivity, artificial intelligence and machine learning analytics, cloud computing infrastructures, and telemedicine platforms. All of these technologies facilitated the ability to conduct uninterrupted biometric surveillance, real-time compliance, predictive risk-stratification, therapeutic optimization, and secure data integration and enhance virtual pharmacist-controlled consultations to manage chronic diseases. RPM technologies show high prospects in evolving pharmacist-led virtual care and managing pharmacotherapy through precision. The necessary changes to sustainably integrate into any pharmacy practice are creating detailed competency frameworks, enhancing data governance, regulatory clarity, and developing approaches to achieve equitable digital health access. Remote patient monitoring technologies transform the pharmacist clinical role broadening it to include data-driven medication management (DDMM). AI, IoT and telemedicine are combined to enhance pharmacovigilance and maximizing the therapy in virtual care models. To encourage sustainable adoption in the pharmacy practice there is a need to address regulatory Interoperability and digital competency gaps.
Venkatesan et al. (2026) studied this question.